Canopy Growth

Canopy Growth

Canopy Growth Corporation is a world-leading diversified cannabis company. We operate a collection of diverse brands and curated strain variety, supported millions of square feet of indoor greenhouse production capacity, partnered with some of the leading names in the sector.
Summary
Fiscal year-end
March
Headquarters
Smith Falls, ON
Licensed Facilities
13
Number of Patients
~74,000
Financials (Pro Forma 6/30)
Cash on hand
$429 million
Fixed investment
$661 million
Shareholders’ equity
$2.98 billion
Revenues – last quarter
$25.3 million
Adj. gross margin
28.2%
EPS
$-1.52
Capital Structure
Capital structure
11/13/18
Last financing
$5 billion Constellation Investment
Basic shares
328.2 million
Warrants
159.6 million
Options
22.2 million
Diluted shares
522.4 million

Canopy Growth News

6 hours ago

Better Buy: Canopy Growth vs. Scotts Miracle-Gro

Which stock wins in a battle between the biggest cannabis producer by market cap and the biggest supplier to the cannabis industry?

11 hours ago

The Week In Cannabis: Colorado Hits $1B In Sales, Harborside In Canada, Kroger Embraces CBD, And More

In Canada, a committee in the House of Commons called for the decriminalization of the possession of small amounts of drugs, while the U.S. House of Representatives rejected an amendment that Rep. Alexandria...

12 hours ago

4 of the 14 Most Widely Held Stocks on Investing App Robinhood Are Marijuana Stocks

Millennials love cannabis stocks. Unfortunately, two of their favorites could be duds.

1 day ago

The Best Cannabis Stock to Buy in June

This industry leader can help you earn a marijuana-fueled fortune.

14 Jun

Marijuana Companies in Canada Have to Delay Their Rollout of ‘Cannabis 2.0’ Products

The slow takeoff of recreational marijuana sales in Canada was expected to gain speed when Canada planned to allow sales of vapes, edibles, beverages, and the popular CBD. Now that’s been delayed.

14 Jun

CGC Stock Continues Week of Losses for Pot Stocks

Canopy Growth Corp (NYSE:CGC) closed down 2.29% on Thursday, with CGC stock at $41.86 -- nearly one dollar lower than its Monday open after spiking over $44 on Tuesday. What caused the latest slide in...

14 Jun

Canopy Growth and Acreage Holdings Remind Shareholders to Vote FOR Canopy Growth's Plan to Acquire Acreage

Canopy Growth's brands, technology and know-how is anticipated to provide Acreage with a significant advantage in an increasingly competitive U.S. market and fuel Acreage's growth. Acreage shareholders...

14 Jun

Department Of Justice Delays Cresco Labs/Origin House Deal

All images are from Cresco Labs . Summary Cresco Labs ( OTCQX:CRLBF ) announced a C$1.1 billion acquisition of Origin House ( OTCQX:ORHOF ) in early April. I published details of this in my article,...

14 Jun

Canopy Growth eyes U.S. market through Acreage

Canopy Growth (NYSE: CGC ) says the deal to acquire Acreage represents a clear path for the company to enter the U.S. cannabis market when it becomes legal on a federal level. More news on: Canopy Growth...

13 Jun

Health Canada briefing tomorrow on next steps in weed regulation

Health Canada officials will hold a media briefing tomorrow, June 14, at 12:30 pm ET to discuss the next steps in the legalization and regulation of cannabis there. More news on: Tilray, Inc., Aurora...

Load more

About Canopy Growth

Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.

Our Story
In April 2014, Canopy Growth became the first cannabis company in North America to be publicly traded. We followed that with being the first to complete a “bought deal”, to diversify our platform to include both greenhouse and indoor growing, to acquire a major competitor and to be listed on the Toronto Stock Exchange. Continuing those firsts, we remain the only cannabis company to be a member of a major global stock market index, in this case the S&P/TSX Composite index.

Away from the markets, Tweed, a Canopy Growth subsidiary, was the first to introduce the now standard concept of Compassionate Pricing to make medical cannabis affordable for patients, and we remain proud to continue supporting a patient’s right to grow at home by selling the widest variety of seeds in the legal Canadian sector. Our commitment to education has and always will be unwavering, as one of the first Canadian cannabis companies to offer Mainpro-M1 accredited continuing medical education programs to Canadian physicians, and to launch in-person assistance through our Tweed Main Street locations. Tweed was also the first Canadian producer to be approved to export dried cannabis to Germany, and our wholly-owned German subsidiary continues to offer an ever-increasing variety of products for sale through German pharmacies. Canopy Growth was the first to strike a strategic relationship with a Fortune 500 beverage alcohol supplier to bring exciting new products to market, and to enter into ground-breaking supply agreements to sell adult-use cannabis to provincial governments across the country. Most recently, in May 2018, it was the first cannabis-producing company to be listed on the New York Stock Exchange.

From our cutting edge research at Canopy Health Innovations, to our hemp operations and financing services through Canopy Rivers Corporation, we are proud of our accomplishments, and are always looking for the next first.

Our Story

In April 2014, Canopy Growth became the first cannabis company in North America to be publicly traded. We followed that with being the first to complete a “bought deal”, to diversify our platform to include both greenhouse and indoor growing, to acquire a major competitor and to be listed on the Toronto Stock Exchange. Continuing those firsts, we remain the only cannabis company to be a member of a major global stock market index, in this case the S&P/TSX Composite index.

Away from the markets, Tweed, a Canopy Growth subsidiary, was the first to introduce the now standard concept of Compassionate Pricing to make medical cannabis affordable for patients, and we remain proud to continue supporting a patient’s right to grow at home by selling the widest variety of seeds in the legal Canadian sector. Our commitment to education has and always will be unwavering, as one of the first Canadian cannabis companies to offer Mainpro-M1 accredited continuing medical education programs to Canadian physicians, and to launch in-person assistance through our Tweed Main Street locations. Tweed was also the first Canadian producer to be approved to export dried cannabis to Germany, and our wholly-owned German subsidiary continues to offer an ever-increasing variety of products for sale through German pharmacies. Canopy Growth was the first to strike a strategic relationship with a Fortune 500 beverage alcohol supplier to bring exciting new products to market, and to enter into ground-breaking supply agreements to sell adult-use cannabis to provincial governments across the country. Most recently, in May 2018, it was the first cannabis-producing company to be listed on the New York Stock Exchange.

From our cutting edge research at Canopy Health Innovations, to our hemp operations and financing services through Canopy Rivers Corporation, we are proud of our accomplishments, and are always looking for the next first.

Here’s to Future Growth.

Corporate Governance

Canopy Growth Corporation’s ISS Governance QualityScore as of January 28, 2019 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Features Canopy Growth

Canadian Operations

  • A leading publicly traded producer in terms of revenue, grams shipped and registered medical patients
  • 4.3 million-square-foot licensed footprint with plans for expansion to 5.6 million square feet
  • Multiple production facilities in provinces including Alberta, British Columbia, Saskatchewan, Ontario, Québec, New Brunswick, and Newfoundland
  • Cannabis supply agreements in Alberta, Quebec, Newfoundland & Labrador, Manitoba, British Columbia, New Brunswick, Prince Edward Island, Northwest Territory, Nunavut, and the Yukon
  • First publicly-traded LP (April 2014) and first to attain listing on the Toronto Stock Exchange (August 2016) and the New York Stock Exchange (May 2018)
  • $5 billion CAD investment from Constellation Brands
  • Brick-and-mortar presence with Tweed brand and Tokyo Smoke stores
  • Curated CraftGrow line from Tweed
  • Strategic relationship with operating platform Canopy Rivers and wholly-owned biopharmaceutical subsidiary Canopy Health Innovations
  • Investment in hemp research through Green Hemp Industrie and ebbu acquisitions

Global Operations 

  • Operating across five continents
  • International subsidiaries and partnerships in Germany, Chile, Columbia, Denmark, Jamaica, Lesotho, Australia, Brazil, Czech Republic, Spain, Poland, and the UK
  • Export agreements in Australia, Brazil, Czech Republic, Denmark, Germany, and Spain
  • Strong international presence through Spectrum including Spektrum in Germany, Spectrum Demark, Spectrum Czech, Spectrum Australia, Spectrum Lesotho, Spectrum Cannabis Colombia, and Spectrum Chile
    Canopy LATAM, based in Brazil, to advance medical cannabis under the Spectrum brand
  • 49% ownership of Jamaican company Tweed JA
  • New York hemp license and plans to establish commercial operations in the U.S.

Financials Canopy Growth

  • 06/15/18 – Size: $600.0mm – Security: 4.25% Convertible Notes – Price: $48.18
  • 01/17/18 – Size: $200.0mm – Security: 5.8mm common shares – Price: $34.60
  • 11/02/17 – Size: $245mm – Security: 18.9mm common shares and 18.9mm warrants at $12.98 (Constellation Brands strategic investment) – Price: $12.98
  • 07/26/17 – Size: $25mm – Security: 3.1mm common shares via private placement – Price: $8.05
  • 03/22/17 – Size: $24.25mm – Security: 2.5mm common shares via private placement – Price: $9.70
  • 12/5/16 – Size: $60.0mm – Security: 5.662mm common shares – Price: $10.60
  • 8/8/16 – Size: $34.5mm – Security: 9.453mm common shares – Price: $3.65
  • 3/22/16 – Size: $11.5mm – Security: 5mm common shares – Price: $2.30
  • 10/23/15 – Size: $14.4mm – Security: 7.01mm common shares – Price $2.05 

Participation in events

Jobs

Position
City
Type
Salary
Posted
CITY:
Delta British Columbia, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
08 Jun 2019
CITY:
Yorkton Saskatchewan, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
27 Mar 2019
CITY:
Toronto Ontario, Canada
TYPE:
Full-Time
SALARY:
DOE
POSTED:
26 Feb 2019
$ 41.18
-1.62%
Open:
41.26
High:
41.65
Low:
40.45
Share volume:
759.211 K
Total value:
35.195 M
Market cap:
14.186 B
Symbol:
CGC